Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
about
Overview of immunology of oral squamous cell carcinomaPreliminary study of in vivo autofluorescence of nasopharyngeal carcinoma and normal tissue.Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinomaSerum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinomaEpstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infectionSensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.Expression of beta-2-microglobulin by nasopharyngeal carcinomaIn vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytesSerum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test.Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis.Emerging biomarkers in head and neck cancer in the era of genomics.IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.Large retropharyngeal abscess: a case of mistaken identity.Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology.Epstein-Barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas.Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.Peripheral gamma delta T-cell deficit in nasopharyngeal carcinoma.Tumour-specific antibodies of the IgA class in rats after the implantation of a syngeneic tumour in the gut.Cytomegalovirus infection of the nasopharynx.Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus.A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the Tolerable Upper Intake Level of SodiumScreening for family members of patients with nasopharyngeal carcinoma.Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 cases.Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong.Epstein-Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba, and its value for differential diagnosis of the disease.Narrow band imaging endoscopy of the nasopharynx is not more useful than white light endoscopy for suspected nasopharyngeal carcinoma.A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma.Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
P2860
Q28079096-B7E43527-62C6-4C5B-96A6-334FD7D45245Q30881653-86356AA2-26CF-4E72-8E41-D6CCB77267ABQ33422245-4AF77290-B2F2-457F-A9F3-98DF73012BE1Q33841441-6191158B-A74F-42DC-9197-E9E48912BD42Q33847587-89CB59C7-2234-47DB-8FFD-2E17BB963AA1Q33973347-E7AA7FE4-7E98-4FB7-A248-DD0C78890CABQ35053419-DE5DC3C6-380E-4060-B704-85274515B4A8Q35160206-01CDD668-3471-493A-83CB-A8929DC6A2F1Q35824288-361C4FEA-349F-4950-B52A-54004A1B3958Q35994404-43100C28-1DAA-467F-BCCE-888C9E99B62AQ36069431-4B1089B6-16A8-46AD-8454-E0B733A95E55Q37183338-3A0E5B48-0C28-4283-A471-3998010B226CQ37316066-FEC9D0F3-194F-4DC8-99EC-D37AA107D643Q38268896-EE916FD5-3BFA-4999-8E84-B653D1333CA5Q38885009-81748F6F-4AE0-47AF-8C51-6D5FB90E0BD2Q38888811-7924EB9B-7DBC-42C3-8B7F-52532314F219Q38956518-C54A8A5A-E028-4CE3-8600-2AEB522C4A0CQ38970947-AE368EF8-EAD2-442E-8B9C-8B298B8686E1Q39122161-922D81CD-8800-49BD-9957-4F7B1FBAA928Q39527194-D717E228-7C73-4B8F-BD1F-DC9AE1C5CEA8Q40077434-ADDB060A-B192-47B9-8D62-411B55FA73D6Q40112258-6DAA841B-6B35-4770-A235-B79CBD1E745AQ40178528-6E4763D6-E028-4182-B111-EC4B17805BC6Q40285770-4EB556A2-4DD2-45FE-B7FF-0EE5CA1AB2CFQ40346047-36FF0509-4852-4B15-BFE4-C96AC48FE51FQ40735445-4BF4A747-9F22-4181-A348-35679C56F1BFQ41476898-B364885B-5155-44F9-A453-1484DF349A5AQ42026784-04B38E2E-AC5E-49CD-805A-28021189DC18Q44770487-570BE1C6-19D0-4A45-BB2A-418D2BA71A3EQ45783034-EC878D0C-FF46-45EE-9F7A-6B0BBDD740A5Q47143781-90B40D3F-4B87-48C5-B69C-DE11DF4A2DD9Q50751206-F7B8DE99-61E9-4D75-9E80-D5BE52224252Q51033851-BC3DF6F1-71F6-4D70-BDB4-A1C2F9974A4EQ51137004-222F1500-98A2-49E5-9B33-A23790D5713DQ52644901-B139C5F4-D3CE-4915-9CB4-BB75CDCA572DQ53169776-8B7C185F-2684-4F58-A500-321958D35986Q53943053-3F62BE53-F880-489F-8D7D-B156E3866FD1Q54254993-272A0424-ADBC-4497-8EBC-3D0201D455D1Q57262055-8AABA772-EB94-475A-9992-AA022E430F43
P2860
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
@en
type
label
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
@en
prefLabel
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1476
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1976.228
P407
P577
1976-12-01T00:00:00Z
P5875
P6179
1008681477